95 related articles for article (PubMed ID: 92357)
1. ["Non-specific cross reacting antigen (NCA)", a tracer of human granulocytes and monocytes].
Burtin P
C R Seances Soc Biol Fil; 1979; 173(2):261-9. PubMed ID: 92357
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
4. Presence of NCA (nonspecific cross-reacting antigen) in the cells of the human granulocyte series.
Burtin P; Flandrin G; Fondaneche MC
Blood Cells; 1980; 6(2):263-78. PubMed ID: 6991029
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces.
Kuroki M; Koga Y; Matsuoka Y
Cancer Res; 1981 Feb; 41(2):713-20. PubMed ID: 6160910
[TBL] [Abstract][Full Text] [Related]
7. Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum.
Ferrara RM; Biancardi C; Cavalca V; Botta M; Bailo M; Bartorelli A
Cancer Detect Prev; 1987; 10(1-2):101-8. PubMed ID: 3568003
[TBL] [Abstract][Full Text] [Related]
8. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations].
Matsuoka Y; Kuroki M; Koga Y
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):575-84. PubMed ID: 6192762
[TBL] [Abstract][Full Text] [Related]
9. Production and characterization of monoclonal antibodies against carcinoembryonic antigen (CEA).
Jantscheff P; Böttger V; Price M; Micheel B; Kaiser G; Zotter S; Kotzsch M; Grossmann H; Karsten U
Biomed Biochim Acta; 1991; 50(12):1261-7. PubMed ID: 1824544
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
Kuroki M; Kuroki M; Koga Y; Matsuoka Y
J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
[TBL] [Abstract][Full Text] [Related]
11. Expression of carcinoembryonic or related cross-reacting antigens in primary pediatric neuroectodermal brain tumors.
Bodey B; Siegel SE; Peacock JS
Mod Pathol; 1992 Jul; 5(4):432-8. PubMed ID: 1323111
[TBL] [Abstract][Full Text] [Related]
12. The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
Ross DD; Gao Y; Yang W; Leszyk J; Shively J; Doyle LA
Cancer Res; 1997 Dec; 57(24):5460-4. PubMed ID: 9407950
[TBL] [Abstract][Full Text] [Related]
13. Characterization of carcinoembryonic antigen-specific monoclonal antibodies and specific carcinoembryonic antigen assay in sera of patients.
Kitagawa H; Ohkouchi E; Fukuda A; Imai K; Yachi A
Jpn J Cancer Res; 1986 Sep; 77(9):922-30. PubMed ID: 2429946
[TBL] [Abstract][Full Text] [Related]
14. [Antigenic structure of NCA-2 from meconium and comparison with normal fecal antigen from adult feces and carcinoembryonic antigen from malignant tissues].
Kuriyama H
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):301-9. PubMed ID: 6201714
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of carcinoembryonic antigens and non cross-reacting antigens in the human thymus. Analysis on frozen sections and cultured epithelial cells using monoclonal antibodies.
Aubry J; Cohen-Kaminsky S; Berrih-Aknin S
Thymus; 1990 Mar; 15(2):107-23. PubMed ID: 2185585
[TBL] [Abstract][Full Text] [Related]
16. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
[TBL] [Abstract][Full Text] [Related]
17. Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA).
Chavanel G; Frenoy N; Escribano MJ; Burtin P
Oncodev Biol Med; 1983; 4(3):209-17. PubMed ID: 6402767
[TBL] [Abstract][Full Text] [Related]
18. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
Burtin P; Chavanel G; Hendrick JC; Frenoy N
J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.
Kantor J; Irvine K; Abrams S; Snoy P; Olsen R; Greiner J; Kaufman H; Eggensperger D; Schlom J
Cancer Res; 1992 Dec; 52(24):6917-25. PubMed ID: 1458480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
